Clinitech Laboratory Ltd Financials

Clinitech Laboratory Ltd Financial Statement

Clinitech Laboratory Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Clinitech Laboratory Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	6.40	6.35	6.38
Operating Expenses Annual	5.42	5.00	5.32
Operating Profit Annual	1.02	1.37	1.14
Interest Annual	0.07	0.06	0.06
Depreciation	0.44	0.45	0.38
Net Profit Annual	0.37	0.61	0.51
Tax Annual	0.13	0.25	0.19

Particulars	Mar 2024
Total Revenue Annual	6.40
Operating Expenses Annual	5.42
Operating Profit Annual	1.02
Interest Annual	0.07
Depreciation	0.44
Net Profit Annual	0.37
Tax Annual	0.13

Clinitech Laboratory Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.78	0.10	0.32
Cash Flow from Operations	0.11	1.25	0.96
Cash Flow from Investing	-0.64	-0.65	-1.47
Cash Flow from Financing	0.45	0.09	0.29
Cash Flow at the End	0.70	0.78	0.10

Particulars	Mar 2024
Cash Flow at the Beginning	0.78
Cash Flow from Operations	0.11
Cash Flow from Investing	-0.64
Cash Flow from Financing	0.45
Cash Flow at the End	0.70

Clinitech Laboratory Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	16.09	21.73	17.87
PBIT Margin (%)	9.22	14.65	11.91
PBT Margin (%)	-93.28	-194.64	-186.68
Net PROFIT Margin (%)	5.78	9.61	7.99
Return On Networth / Equity (%)	12.48	28.84	31.48
Return On Networth /Employed (%)	12.25	23.60	31.15
Return On Assets (%)	7.69	15.47	20.86
Total Debt / Equity (X)	0.32	0.45	0.44
Asset Turnover Ratio (%)	1.33	1.61	2.61

Particulars	Mar 2024
PBDIT Margin (%)	16.09
PBIT Margin (%)	9.22
PBT Margin (%)	-93.28
Net PROFIT Margin (%)	5.78
Return On Networth / Equity (%)	12.48
Return On Networth /Employed (%)	12.25
Return On Assets (%)	7.69
Total Debt / Equity (X)	0.32
Asset Turnover Ratio (%)	1.33

Clinitech Laboratory Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	2.66	1.89	2.06
Total Current Assets Annual	2.71	1.96	1.38
Non Current Assets Annual	2.90	4.07	2.30
Total Shareholders Funds Annual	3.55	2.38	1.85
Total Assets Annual	5.61	6.03	3.69

Particulars	Mar 2024
Fixed Assets Annual	2.66
Total Current Assets Annual	2.71
Non Current Assets Annual	2.90
Total Shareholders Funds Annual	3.55
Total Assets Annual	5.61

Clinitech Laboratory Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 24, 2024, Clinitech Laboratory Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Clinitech Laboratory Ltd is debt-free with a debt-to-equity ratio of 0.24.

In FY 2023 , Clinitech Laboratory Ltd recorded a total revenue of approximately 6.40 Cr marking a significant milestone in the company's financial performance.

Clinitech Laboratory Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.0% annually, respectively..

Clinitech Laboratory Ltd's current PE ratio is undefined.

Clinitech Laboratory Ltd's ROCE averaged 19.9% from the FY ending March 2022 to 2024, with a median of 18.8%. It peaked at 27.7% in March 2022, reflecting strong capital efficiency over the period..

Clinitech Laboratory Ltd's latest EBIT is Rs. 0.58 Cr, surpassing the average EBIT of Rs. 0.75 Cr over the 5 years..